{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:54:29Z","timestamp":1788821669629,"version":"build-2803163510"},"reference-count":118,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2025,6,15]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:p>We present a review of mature B-cell neoplasms as described in the fifth edition of the WHO classification of haematolymphoid tumours (WHO-HAEM5). Entities have expanded, and definitions are increasingly reliant on genomic and other technologies. However, the WHO-HAEM5 employs a hierarchical structure with family (class)-level definitions that group several specific entities. This approach enables the assignment of a family-level diagnosis when criteria for specific entities cannot be met due to resource constraints. To facilitate application in resource-limited settings, WHO-HAEM5 divides diagnostic criteria into \u2018essential\u2019 and desirable criteria for most entities. This review focuses on changes and updates in B-cell lymphoma classification, providing guidance on how to apply the WHO classification in resource-limited settings.<\/jats:p>","DOI":"10.1136\/jcp-2025-210260","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T07:35:33Z","timestamp":1755070533000},"page":"725-739","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Fifth edition WHO classification: mature B-cell neoplasms"],"prefix":"10.1136","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3807-3638","authenticated-orcid":false,"given":"Kikkeri N","family":"Naresh","sequence":"first","affiliation":[{"name":"Section of Pathology, Translational Science and Therapeutics Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"},{"name":"Department of Laboratory Medicine & Pathology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennosuke","family":"Karube","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Nagoya University, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Borges","sequence":"additional","affiliation":[{"name":"Centre for Oncopathology, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wah","family":"Cheuk","sequence":"additional","affiliation":[{"name":"Department of Pathology, Queen Elizabeth Hospital, Hong Kong, SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet","family":"Gujral","sequence":"additional","affiliation":[{"name":"Department of Pathology, Tata Memorial Hospital, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahin","family":"Sayed","sequence":"additional","affiliation":[{"name":"Department of Pathology, Aga Khan University Hospital, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6307-4854","authenticated-orcid":false,"given":"Aliyah","family":"Sohani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Lazzi","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, University of Siena, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Klinische Pathologie, Robert-Bosch-Krankenhaus, Stuttgart, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1017-5045","authenticated-orcid":false,"given":"Ming-Qing","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Leoncini","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, University of Siena, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K C","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Queen Elizabeth Hospital, Hong Kong, SAR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"2025101712350632000_78.11.725.1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jcp-2025-210135","article-title":"Fifth edition WHO classification: precursor lymphoid neoplasms, acute leukaemias of mixed or ambiguous lineage, myeloid\/lymphoid neoplasms, and histiocytic and dendritic cell neoplasms, including strategies for application in resource-limited settings","volume":"PMID","author":"Tembhare","year":"2025","journal-title":"J Clin Pathol"},{"key":"2025101712350632000_78.11.725.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2"},{"key":"2025101712350632000_78.11.725.3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.humpath.2017.11.002","article-title":"Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma","volume":"72","author":"El Behery","year":"2018","journal-title":"Hum Pathol"},{"key":"2025101712350632000_78.11.725.4","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/PAS.0000000000001726","article-title":"High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B","volume":"45","author":"Laurent","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"2025101712350632000_78.11.725.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-168682"},{"key":"2025101712350632000_78.11.725.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-132415"},{"key":"2025101712350632000_78.11.725.7","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181f72835"},{"key":"2025101712350632000_78.11.725.8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jaad.2013.04.047","article-title":"Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients","volume":"69","author":"Servitje","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2025101712350632000_78.11.725.9","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1182\/blood.2024025794","article-title":"EMZL at various sites: learning from each other","volume":"145","author":"Du","year":"2025","journal-title":"Blood"},{"key":"2025101712350632000_78.11.725.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-021-03186-3"},{"key":"2025101712350632000_78.11.725.11","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1038\/s41375-021-01289-z","article-title":"Thyroid MALT lymphoma: self-harm to gain potential T-cell help","volume":"35","author":"Wu","year":"2021","journal-title":"Leukemia"},{"key":"2025101712350632000_78.11.725.12","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jid.2018.02.015","article-title":"Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma","volume":"138","author":"Maurus","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2025101712350632000_78.11.725.13","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12614479"},{"key":"2025101712350632000_78.11.725.14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.091702"},{"key":"2025101712350632000_78.11.725.15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1182\/bloodadvances.2020001608","article-title":"Cold agglutinin-associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18","volume":"4","author":"Ma\u0142ecka","year":"2020","journal-title":"Blood Adv"},{"key":"2025101712350632000_78.11.725.16","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/bjh.15063","article-title":"Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease","volume":"183","author":"Ma\u0142ecka","year":"2018","journal-title":"Br J Haematol"},{"key":"2025101712350632000_78.11.725.17","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2828"},{"key":"2025101712350632000_78.11.725.18","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqw060"},{"key":"2025101712350632000_78.11.725.19","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18404"},{"key":"2025101712350632000_78.11.725.20","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-023-00462-z","article-title":"Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter study","volume":"11","author":"Zha","year":"2023","journal-title":"Biomark Res"},{"key":"2025101712350632000_78.11.725.21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw185"},{"key":"2025101712350632000_78.11.725.22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.3260"},{"key":"2025101712350632000_78.11.725.23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/17474086.2016.1199948","article-title":"Richter transformation of CLL","volume":"9","author":"Jain","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"2025101712350632000_78.11.725.24","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31826cb1d1"},{"key":"2025101712350632000_78.11.725.25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569"},{"key":"2025101712350632000_78.11.725.26","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.1016\/S1590-8658(11)60587-2","article-title":"Gastric lymphoma: the histology report","volume":"43 Suppl 4","author":"Doglioni","year":"2011","journal-title":"Dig Liver Dis"},{"key":"2025101712350632000_78.11.725.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2005.02309.x"},{"key":"2025101712350632000_78.11.725.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.12.027"},{"key":"2025101712350632000_78.11.725.29","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.022277"},{"key":"2025101712350632000_78.11.725.30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2141.1986.tb07575.x","article-title":"The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. II. Patterns of evolution of \u201cprolymphocytoid\u201d transformation","volume":"64","author":"Melo","year":"1986","journal-title":"Br J Haematol"},{"key":"2025101712350632000_78.11.725.31","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.42.6.567"},{"key":"2025101712350632000_78.11.725.32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05716.x"},{"key":"2025101712350632000_78.11.725.33","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3324\/haematol.2021.279351","article-title":"Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present a histopathological and molecular continuum lacking features of progression\/ transformation","volume":"107","author":"Koch","year":"2022","journal-title":"Haematologica"},{"key":"2025101712350632000_78.11.725.34","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-004-3390-7"},{"key":"2025101712350632000_78.11.725.35","doi-asserted-by":"crossref","DOI":"10.1186\/s40942-018-0120-4","article-title":"The diagnosis and treatment of primary vitreoretinal lymphoma: a review","volume":"4","author":"Pulido","year":"2018","journal-title":"Int J Retina Vitreous"},{"key":"2025101712350632000_78.11.725.36","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199404000-00006"},{"key":"2025101712350632000_78.11.725.37","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1175"},{"key":"2025101712350632000_78.11.725.38","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1182\/blood.2020008376","article-title":"Primary mediastinal large B-cell lymphoma","volume":"140","author":"Savage","year":"2022","journal-title":"Blood"},{"key":"2025101712350632000_78.11.725.39","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000180856.74572.73"},{"key":"2025101712350632000_78.11.725.40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/bjh.15923","article-title":"Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States","volume":"186","author":"Geer","year":"2019","journal-title":"Br J Haematol"},{"key":"2025101712350632000_78.11.725.41","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000328"},{"key":"2025101712350632000_78.11.725.42","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004515"},{"key":"2025101712350632000_78.11.725.43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.09.021"},{"key":"2025101712350632000_78.11.725.44","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182515fb5"},{"key":"2025101712350632000_78.11.725.45","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24251"},{"key":"2025101712350632000_78.11.725.46","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.233"},{"key":"2025101712350632000_78.11.725.47","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-023-00827-5","article-title":"A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications","volume":"13","author":"El-Sharkawi","year":"2023","journal-title":"Blood Cancer J"},{"key":"2025101712350632000_78.11.725.48","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1080\/10428194.2021.1941929","article-title":"Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK\u2009+\u2009LBCL): a systematic review of clinicopathological features and management","volume":"62","author":"Castillo","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"2025101712350632000_78.11.725.49","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjh.16578","article-title":"Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group","volume":"190","author":"Au-Yeung","year":"2020","journal-title":"Br J Haematol"},{"key":"2025101712350632000_78.11.725.50","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/PAS.0000000000001613","article-title":"A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell Lymphomas","volume":"45","author":"Horn","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"2025101712350632000_78.11.725.51","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cancergen.2024.03.001","article-title":"Assessment for 11q and other chromosomal aberrations in large B-cell\/high-grade B cell lymphomas of germinal center phenotype lacking BCL2 expression","volume":"284\u2013285","author":"Ho","year":"2024","journal-title":"Cancer Genet"},{"key":"2025101712350632000_78.11.725.52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/his.14594","article-title":"A refined approach to the diagnosis of Burkitt lymphoma in a resource-poor setting","volume":"80","author":"Naresh","year":"2022","journal-title":"Histopathology"},{"key":"2025101712350632000_78.11.725.53","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.195958"},{"key":"2025101712350632000_78.11.725.54","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.016113"},{"key":"2025101712350632000_78.11.725.55","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2002.01291.x"},{"key":"2025101712350632000_78.11.725.56","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1182\/bloodadvances.2020002293","article-title":"Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis","volume":"4","author":"Kaji","year":"2020","journal-title":"Blood Adv"},{"key":"2025101712350632000_78.11.725.57","doi-asserted-by":"publisher","DOI":"10.1111\/his.13336"},{"key":"2025101712350632000_78.11.725.58","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-567479"},{"key":"2025101712350632000_78.11.725.59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199505043321802"},{"key":"2025101712350632000_78.11.725.60","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqw218"},{"key":"2025101712350632000_78.11.725.61","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-3814"},{"key":"2025101712350632000_78.11.725.62","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jnen\/nlz125","article-title":"Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma","volume":"79","author":"B\u00f6d\u00f6r","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"2025101712350632000_78.11.725.63","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-10-673236"},{"key":"2025101712350632000_78.11.725.64","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017009472"},{"key":"2025101712350632000_78.11.725.65","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007507"},{"key":"2025101712350632000_78.11.725.66","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature New Biol"},{"key":"2025101712350632000_78.11.725.67","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-05-1545"},{"key":"2025101712350632000_78.11.725.68","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/PAI.0000000000000843","article-title":"Comparison of the Lymph2Cx Assay and Hans Algorithm in Determining the Cell-of-Origin of Diffuse Large B-Cell Lymphomas, Not Otherwise Specified","volume":"28","author":"Cho","year":"2020","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2025101712350632000_78.11.725.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.09.027"},{"key":"2025101712350632000_78.11.725.70","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0016-8"},{"key":"2025101712350632000_78.11.725.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.03.015"},{"key":"2025101712350632000_78.11.725.72","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.091827"},{"key":"2025101712350632000_78.11.725.73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2012.04301.x"},{"key":"2025101712350632000_78.11.725.74","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-297879"},{"key":"2025101712350632000_78.11.725.75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/PAS.0000000000001750","article-title":"Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms: A Multiparameter Study of a Rare and Aggressive Entity","volume":"46","author":"Bhavsar","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"2025101712350632000_78.11.725.76","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-842088"},{"key":"2025101712350632000_78.11.725.77","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-507996"},{"key":"2025101712350632000_78.11.725.78","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.humpath.2023.03.013","article-title":"High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic, and molecular characterization of 4 cases","volume":"136","author":"Shestakova","year":"2023","journal-title":"Hum Pathol"},{"key":"2025101712350632000_78.11.725.79","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.3324\/haematol.2019.235556","article-title":"A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients","volume":"105","author":"Ziepert","year":"2020","journal-title":"Haematologica"},{"key":"2025101712350632000_78.11.725.80","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/PAS.0000000000000839","article-title":"LMO2-negative Expression Predicts the Presence of MYC Translocations in Aggressive B-Cell Lymphomas","volume":"41","author":"Colomo","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"2025101712350632000_78.11.725.81","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-323238"},{"key":"2025101712350632000_78.11.725.82","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-04-842559"},{"key":"2025101712350632000_78.11.725.83","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.1909"},{"key":"2025101712350632000_78.11.725.84","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-747477"},{"key":"2025101712350632000_78.11.725.85","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0095-RA"},{"key":"2025101712350632000_78.11.725.86","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/PAS.0000000000001271","article-title":"Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors","volume":"43","author":"Kurita","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"2025101712350632000_78.11.725.87","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020004058"},{"key":"2025101712350632000_78.11.725.88","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3182a8338f"},{"key":"2025101712350632000_78.11.725.89","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318160ed97"},{"key":"2025101712350632000_78.11.725.90","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/bjh.14633","article-title":"Mutational landscape of B-cell post-transplant lymphoproliferative disorders","volume":"178","author":"Menter","year":"2017","journal-title":"Br J Haematol"},{"key":"2025101712350632000_78.11.725.91","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/bjh.17708","article-title":"EBV\u2010positive HIV\u2010associated diffuse large B cell lymphomas are characterized by JAK\/STAT (STAT3) pathway mutations and unique clinicopathologic features","volume":"194","author":"Chapman","year":"2021","journal-title":"Br J Haematol"},{"key":"2025101712350632000_78.11.725.92","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/ajt.13558","article-title":"EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features","volume":"16","author":"Ferreiro","year":"2016","journal-title":"Am J Transplant"},{"key":"2025101712350632000_78.11.725.93","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001012"},{"key":"2025101712350632000_78.11.725.94","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-871418"},{"key":"2025101712350632000_78.11.725.95","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130270"},{"key":"2025101712350632000_78.11.725.96","doi-asserted-by":"crossref","first-page":"152286","DOI":"10.1016\/j.anndiagpath.2024.152286","article-title":"Epstein-Barr virus latency patterns in polymorphic lymphoproliferative disorders and lymphomas in immunodeficiency settings: Diagnostic implications","volume":"70","author":"Volaric","year":"2024","journal-title":"Ann Diagn Pathol"},{"key":"2025101712350632000_78.11.725.97","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020328","article-title":"Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes","volume":"12","author":"Fujimoto","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2025101712350632000_78.11.725.98","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.186"},{"key":"2025101712350632000_78.11.725.99","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajcp\/aqw215","article-title":"Primary\/Congenital Immunodeficiency: 2015 SH\/EAHP Workshop Report-Part 5","volume":"147","author":"Gratzinger","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"2025101712350632000_78.11.725.100","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqw214"},{"key":"2025101712350632000_78.11.725.101","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2014.82","article-title":"EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management","volume":"47","author":"Ok","year":"2015","journal-title":"Exp Mol Med"},{"key":"2025101712350632000_78.11.725.102","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200310000-00007"},{"key":"2025101712350632000_78.11.725.103","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-515825"},{"key":"2025101712350632000_78.11.725.104","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2022-208190"},{"key":"2025101712350632000_78.11.725.105","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/jha2.690","article-title":"MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte\u2010predominant Hodgkin lymphoma","volume":"4","author":"Torabi","year":"2023","journal-title":"eJHaem"},{"key":"2025101712350632000_78.11.725.106","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.8869"},{"key":"2025101712350632000_78.11.725.107","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2015.133025"},{"key":"2025101712350632000_78.11.725.108","doi-asserted-by":"crossref","DOI":"10.1186\/2052-1839-14-11","article-title":"Case report: a 37-year-old male with telangiectasias, polycythemia vera, perinephric fluid collections, and intrapulmonary shunting","volume":"14","author":"Khan","year":"2014","journal-title":"BMC Hematol"},{"key":"2025101712350632000_78.11.725.109","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfs139"},{"key":"2025101712350632000_78.11.725.110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jbspin.2015.06.011","article-title":"Coexistence of rheumatoid arthritis and TEMPI syndrome: New insight in microangiogenic-related diseases","volume":"83","author":"Pascart","year":"2016","journal-title":"Joint Bone Spine"},{"key":"2025101712350632000_78.11.725.111","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood.2020005674","article-title":"Cold agglutinin disease revisited: a multinational, observational study of 232 patients","volume":"136","author":"Berentsen","year":"2020","journal-title":"Blood"},{"key":"2025101712350632000_78.11.725.112","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMra1810907","article-title":"Monoclonal Gammopathy of Renal Significance","volume":"384","author":"Leung","year":"2021","journal-title":"N Engl J Med"},{"key":"2025101712350632000_78.11.725.113","first-page":"25","article-title":"Adenopathy and Extensive Skin Patch Overlying a Plasmacytoma (AESOP) Syndrome","volume":"5","author":"Farooq","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"key":"2025101712350632000_78.11.725.114","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-03-1038"},{"key":"2025101712350632000_78.11.725.115","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.247"},{"key":"2025101712350632000_78.11.725.116","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.2267"},{"key":"2025101712350632000_78.11.725.117","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41408-021-00587-0","article-title":"Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage","volume":"11","author":"Fern\u00e1ndez de Larrea","year":"2021","journal-title":"Blood Cancer J"},{"key":"2025101712350632000_78.11.725.118","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2007.049130"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jcp-2025-210260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:35:48Z","timestamp":1760729748000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jcp-2025-210260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":118,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,10,17]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/jcp-2025-210260"],"URL":"https:\/\/doi.org\/10.1136\/jcp-2025-210260","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]}}}